U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Prescription Drug User Fee Amendments
  5. Appendix A long description
  1. Prescription Drug User Fee Amendments

Appendix A long description

Seven out of 17 review divisions in OND had Pilot 1 products. The following divisions had Pilot 1 products: Cardiovascular and Renal had 1 product, Gastroenterology had 1 product, Anti-infectives and Ophthalmology had 3 products, Drug Oncology had 3 products, Medical Imaging and Hematology had 1 product, Biological Oncology had 1 product and Therapeutic Biologics had 1 product. Eight out of 17 review divisions in OND had Pilot 2 products. The following divisions had Pilot 1 products: Cardiovascular and Renal had 1 product, Neurology had 1 product, Pulmonary and allergy had 1 product, Gastroenterology had 1 product, Anti-infectives and Ophthalmology had 2 products, Drug Oncology had 1 product, Biological Oncology had 1 product and Therapeutic Biologics had 1 product.

Back to Top